thecardiologyadvisor.com1d
FDA Extends Review of Elamipretide for Barth Syndrome
The FDA has extended the review period for the New Drug Application for elamipretide for the treatment of Barth syndrome.
Scientists Solve Long-Standing DNA Machinery Mystery
SMC proteins can reverse direction, reshaping DNA and solving key scientific debates. This discovery could impact research on ...